Botulinum Neurotoxin for Children With CP: a Delicate Balance Between Clinical Benefits and Muscular Harm
Bo-Balance
1 other identifier
observational
51
1 country
1
Brief Summary
A cross-sectional design study will be carried out to explore the morphological muscle properties and alterations in muscle composition on a macroscopic level in children with spastic cerebral palsy (CP). Muscle composition will be assessed using quantitative Magnetic Resonance Imaging (qMRI) and shear wave elastography (SWE), while macroscopic muscle size properties will be evaluated through 'Three-dimensional freehand ultrasound (3DfUS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2025
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 3, 2025
CompletedFirst Submitted
Initial submission to the registry
May 16, 2025
CompletedFirst Posted
Study publicly available on registry
May 28, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
April 29, 2026
May 1, 2025
3.8 years
May 16, 2025
April 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (9)
Evaluation of the muscle volume of the medial gastrocnemius muscle
Estimation of the muscle belly volume by 3DfUS. Muscle volume will be normalized to anthropometric growth.
Cross-sectional data collection at day 1.
Evaluation of the muscle length of the medial gastrocnemius muscle
Estimation of the muscle belly length, tendon length and muscle tendon unit complex length by 3DfUS. Muscle lengths will be normalized to anthropometric growth
Cross-sectional data collection at day 1.
Evaluation of the muscle echo-intensity of the medial gastrocnemius muscle
Estimation of the echo-intensity by 3DfUS.
Cross-sectional data collection at day 1.
Evaluation of the fat fraction of the medial gastrocnemius muscle.
Estimation of the fat fraction by Dixon sequence (MRI): a comparison of muscle fat fraction between children with CP and healthy age-matched TD controls in different age groups.
Cross-sectional data collection at day 1.
Indirect evaluation of collagen content of the medial gastrocnemius muscle
Indirect estimation of collagen content by T1ƿ relaxation time (MRI): a comparison between children with CP and healthy age-matched TD controls in different age groups.
Cross-sectional data collection at day 1.
Evaluation of passive muscle stiffness across the medial gastrocnemius muscle.
Estimation of the passive muscle stiffness by shear modulus (SWE): a comparison of passive muscle stiffness between children with CP and healthy age-matched TD controls in different age groups.
Cross-sectional data collection at day 1.
Evaluation of differences in fat fraction in different regions across the medial gastrocnemius muscle.
Comparison of differences in fat fraction across three regions (proximal, midbelly, distal) of the muscle belly in children with CP compared to TD children.
Cross-sectional data collection at day 1.
Evaluation of differences in passive muscle stiffness in different regions across the medial gastrocnemius muscle.
Comparison of differences in passive muscle stiffness across three regions (midbelly, distal, upper fascia of midbelly) of the muscle belly in children with CP compared to TD children.
Cross-sectional data collection at day 1.
Evaluation of the muscle strength (ankle torque).
Evaluating the muscle strength (ankle torque) using the handheld dynamometer.
Cross-sectional data collection at day 1.
Study Arms (2)
Children with spastic cerebral palsy
Children between 2 years and 16 years old
Typically developing children
Children between 2 years and 16 years old
Eligibility Criteria
Children with spastic cerebral palsy, who have routine follow-up care at the CP reference center of the University Hospitals Leuven. Typically developing children are recruited through the social (family and friends) and professional (colleagues) network of involved researchers and thesis students, who approach participants through flyers, social media.
You may qualify if:
- Children (boys/girls) with congenital brain lesion, confirmed with neuro-imaging such as MRI
- At high-risk for CP or diagnosed spastic type of CP
- (Suspected) Gross Motor Function Classification Scale (GMFCS) Level I-III
- Uni or bilateral involvement
- Aged between 2-16 years
You may not qualify if:
- Presence of dyskinesia or ataxia
- Severe co-morbidities (cognitive problems)
- BTX treatment in the gastrocnemius in the past 10 months
- Previous surgery at the investigated muscles.
- Previous orthopedic or neurosurgery
- Severe ankle deformities
- Weight for height values \>2SD or \<-2SD from mean
- Typically developing children
- Aged between 2-16 years
- History of neurological, orthopedic or muscular problems
- Involvement in an elite or high-performance sporting program (Children performing the same sports for \> 5 hours/week will be excluded)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UZ Leuven
Leuven, Vlaams-Brabant, 3000, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kaat Desloovere, Prof.dr.
Department of Rehabilitation Sciences, KU Leuven, Belgium
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. dr.
Study Record Dates
First Submitted
May 16, 2025
First Posted
May 28, 2025
Study Start
February 3, 2025
Primary Completion (Estimated)
December 1, 2028
Study Completion (Estimated)
December 1, 2028
Last Updated
April 29, 2026
Record last verified: 2025-05